Drug Type Small molecule drug |
Synonyms Conjugated estrogens/medroxyprogesterone, Methylprogesteron/conjugated estrogens, Premarin/MPA + [8] |
Target |
Mechanism ERs agonists(Estrogen receptors agonists), PR agonists(Progesterone receptor agonists) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (17 Nov 1995), |
Regulation- |
Molecular FormulaC22H32O3 |
InChIKeyFRQMUZJSZHZSGN-HBNHAYAOSA-N |
CAS Registry520-85-4 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Conjugated Estrogens/Medroxyprogesterone Acetate | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Osteoporosis, Postmenopausal | US | 17 Nov 1995 | |
Vasomotor symptom | US | 17 Nov 1995 | |
Vulvovaginal atrophy | US | 17 Nov 1995 |